Loading...
Last submissions
-
Joël Coste, Cyrille Delpierre, Jean-Baptiste Richard, Caroline Alleaume, Anne Gallay, et al.. Prevalence of long COVID in the general adult population according to different definitions and sociodemographic and infection characteristics. A nationwide random sampling survey in France in autumn 2022. Clinical Microbiology and Infection, 2024, 5 (2), pp.e120-e130. ⟨10.1016/j.cmi.2024.03.020⟩. ⟨hal-04942465⟩
-
Romy Younan, Jean Loup Augy, Bertrand Hermann, Bertrand Guidet, Philippe Aegerter, et al.. Severe asthma exacerbation: Changes in patient characteristics, management, and outcomes from 1997 to 2016 in 40 ICUs in the greater Paris area. Journal of Intensive Medicine, 2024, 4 (2), pp.209-215. ⟨10.1016/j.jointm.2023.08.008⟩. ⟨hal-04846247⟩
-
-
-
Nikos Pantazis, Caroline A Sabin, Sophie Grabar, Marc van der Valk, Inma Jarrin, et al.. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration. The Lancet HIV, 2024, 11 (10), pp.e660-e669. ⟨10.1016/S2352-3018(24)00183-8⟩. ⟨inserm-04930571⟩
-
Anders Boyd, Pauline Mathieu, Ugo Françoise, Hayette Rougier, Thibault Chiarabini, et al.. Sexual behaviors and risk of extended-spectrum β-lactamase-producing Enterobacterales carriage: A cross-sectional analysis. International Journal of Infectious Diseases, 2024, 149, pp.107277. ⟨10.1016/j.ijid.2024.107277⟩. ⟨hal-04926447⟩
-
-
Cindy Etienne, Ana Maria Vilcu, Flora Finet, Sylvain Chawki, Thierry Blanchon, et al.. Incidence of serious respiratory tract infections and associated characteristics in a population exposed to immunosuppressive therapies: a register-based population study. BMC Infectious Diseases, 2024, 24 (1), pp.1184. ⟨10.1186/s12879-024-10039-2⟩. ⟨hal-04846199⟩
-
-
-
-
-
-
Eugeni Belda, Jacqueline Capeau, Jean-Daniel Zucker, Emmanuelle Le Chatelier, Nicolas Pons, et al.. Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs. BMC Medical Genomics, 2024, 17 (1), pp.209. ⟨10.1186/s12920-024-01978-5⟩. ⟨hal-04918234⟩
-
-
Diego Quattrone, Laura Ferraro, Giada Tripoli, Caterina La Cascia, Harriet Quigley, et al.. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study. Psychological Medicine, 2020, 51 (8), pp.1329-1337. ⟨10.1017/S0033291720000082⟩. ⟨hal-04907626⟩
-
Ophelia Godin, Guillaume Fond, Ewa Bulzacka, Frank Schürhoff, Laurent Boyer, et al.. Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ). Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2019, 92, pp.226-234. ⟨10.1016/j.pnpbp.2019.01.003⟩. ⟨hal-04905690⟩
-
Antoine Chéret, Rebecca Bauer, Vincent Meiffrédy, Pauline Lopez, Faïza Ajana, et al.. Once-Daily Dolutegravir versus Darunavir plus Cobicistat in Adults at the Time of Primary HIV-1 Infection: The OPTIPRIM2-ANRS 169 Randomized, Open-Label, Phase 3 Trial. Journal of Antimicrobial Chemotherapy, 2022, pp.dkac207. ⟨10.1093/jac/dkac207⟩. ⟨hal-03777513⟩
-
Lucille Calmon, Elisabetta Colosi, Giulia Bassignana, Alain Barrat, Vittoria Colizza. Preserving friendships in school contacts: An algorithm to construct synthetic temporal networks for epidemic modelling. PLoS Computational Biology, 2024, 20 (12), pp.e1012661. ⟨10.1371/journal.pcbi.1012661⟩. ⟨hal-04880267⟩
-
Cyrille Coustal, Radjiv Goulabchand, Pierre Labauge, Philippe Guilpain, Clarisse Carra-Dallière, et al.. Clinical, Radiologic, and Immunologic Features of Patients With CTLA4 Deficiency With Neurologic Involvement. Neurology, 2023, pp.10.1212/WNL.0000000000207609. ⟨10.1212/WNL.0000000000207609⟩. ⟨hal-04172594⟩